Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$9.94 - $12.65 $2,405 - $3,061
-242 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$11.99 - $18.14 $2,901 - $4,389
242 New
242 $2,000
Q2 2021

Jul 22, 2021

SELL
$12.38 - $29.19 $2,995 - $7,063
-242 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$12.34 - $17.92 $2,986 - $4,336
242 New
242 $3,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $13.4M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Horizon Financial Services, LLC Portfolio

Follow Horizon Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Financial Services, LLC with notifications on news.